ATP2B1 and COVID-19: As ATP2B1 has been shown to be downregulated in the lungs of COVID-19 patients (Fig. EV1G,H) and here confirmed in our in vitro-infected cellular models (Fig. 1I), we evaluated if potential genetics associations between ATP2B1 locus and the risk of developing severe COVID-19 occurs.